KNApSAcK Metabolite C00048188
Metabolite
KNApSAcK Entry
| id | C00048188 |
|---|---|
| Name | Taurine |
| CAS RN | 107-35-7 |
| Standard InChI | InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6) |
| Standard InChI (Main Layer) | InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6) |
Cluster
| Phytochemical cluster | |
|---|---|
| KCF-S cluster | No. 3630 |
Link
ChEMBL
| By standard InChI | CHEMBL239243 |
|---|---|
| By standard InChI Main Layer | CHEMBL239243 |
KEGG
| By LinkDB | C00245 |
|---|
CTD
| By CAS RN | D013654 |
|---|
Species
Summary
Plant class
| class name | count |
|---|
Family
| family name | count |
|---|---|
| Axinellidae | 1 |
List (1)
* NCBI
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Axinella polypoides | 12959 | Axinellidae | Metazoa |
Human Protein / Gene in interaction
14 ChEMBL Protein in interactions
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL239243 |
CHEMBL1741321
(1)
|
1 / 0 |
| P04062 | Glucosylceramidase | Enzyme | CHEMBL239243 |
CHEMBL1613818
(1)
|
6 / 4 |
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL239243 |
CHEMBL1794524
(1)
|
0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | CHEMBL239243 |
CHEMBL1614544
(1)
|
11 / 10 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL239243 |
CHEMBL1741325
(1)
|
0 / 1 |
| P54132 | Bloom syndrome protein | Enzyme | CHEMBL239243 |
CHEMBL1614522
(1)
CHEMBL1614067
(1)
|
1 / 2 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL239243 |
CHEMBL1741322
(1)
|
0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL239243 |
CHEMBL1613777
(1)
CHEMBL1741323
(1)
|
1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL239243 |
CHEMBL1741324
(1)
|
0 / 1 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL239243 |
CHEMBL1614211
(1)
|
0 / 0 |
| Q7Z2H8 | Proton-coupled amino acid transporter 1 | Unclassified protein | CHEMBL239243 |
CHEMBL1919336
(2)
|
0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL239243 |
CHEMBL2114890
(1)
|
0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL239243 |
CHEMBL1794536
(1)
|
0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL239243 |
CHEMBL2354311
(1)
|
1 / 0 |
CTD interaction (57)
| compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
|---|---|---|---|---|---|---|---|
| D013654 | 27 |
ABL2
ABLL ARG |
c-abl oncogene 2, non-receptor tyrosine kinase (EC:2.7.10.2) | Taurine results in increased expression of ABL2 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 55803 |
ADAP2
CENTA2 HSA272195 cent-b |
ArfGAP with dual PH domains 2 | Taurine results in increased expression of ADAP2 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 135 |
ADORA2A
A2aR ADORA2 RDC8 |
adenosine A2a receptor | Taurine results in decreased expression of ADORA2A mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 147 |
ADRA1B
ADRA1 ALPHA1BAR |
adrenoceptor alpha 1B | Taurine results in increased expression of ADRA1B mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 637 |
BID
FP497 |
BH3 interacting domain death agonist | Taurine results in decreased expression of BID mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 659 |
BMPR2
BMPR-II BMPR3 BMR2 BRK-3 PPH1 T-ALK |
bone morphogenetic protein receptor, type II (serine/threonine kinase) (EC:2.7.11.30) | Taurine results in decreased expression of BMPR2 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 10486 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) | Taurine results in decreased expression of CAP2 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 10486 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) | Taurine results in increased expression of CAP2 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 1081 |
CGA
CG-ALPHA FSHA GPHA1 GPHa HCG LHA TSHA |
glycoprotein hormones, alpha polypeptide | Taurine results in increased expression of CGA mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 1123 |
CHN1
ARHGAP2 CHN DURS2 NC RHOGAP2 |
chimerin 1 | Taurine results in decreased expression of CHN1 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 9318 |
COPS2
ALIEN CSN2 SGN2 TRIP15 |
COP9 signalosome subunit 2 | Taurine results in increased expression of COPS2 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 2833 |
CXCR3
CD182 CD183 CKR-L2 CMKAR3 GPR9 IP10-R Mig-R MigR |
chemokine (C-X-C motif) receptor 3 | Taurine results in decreased expression of CXCR3 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 23576 |
DDAH1
DDAH |
dimethylarginine dimethylaminohydrolase 1 (EC:3.5.3.18) | Taurine results in decreased expression of DDAH1 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 8525 |
DGKZ
DAGK5 DAGK6 DGK-ZETA hDGKzeta |
diacylglycerol kinase, zeta (EC:2.7.1.107) | Taurine results in increased expression of DGKZ mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 9538 |
EI24
EPG4 PIG8 TP53I8 |
etoposide induced 2.4 | Taurine results in increased expression of EI24 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 355 |
FAS
ALPS1A APO-1 APT1 CD95 FAS1 FASTM TNFRSF6 |
Fas cell surface death receptor | FAS protein results in increased secretion of Taurine |
increases secretion
|
protein |
10864002
|
| D013654 | 2260 |
FGFR1
BFGFR CD331 CEK FGFBR FGFR-1 FLG FLT-2 FLT2 HBGFR HH2 HRTFDS KAL2 N-SAM OGD bFGF-R-1 |
fibroblast growth factor receptor 1 (EC:2.7.10.1) | Taurine results in decreased expression of FGFR1 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 2741 |
GLRA1
HKPX1 STHE |
glycine receptor, alpha 1 | Taurine binds to and results in increased activity of GLRA1 protein |
affects binding
/ increases activity |
protein |
15081878
|
| D013654 | 2917 |
GRM7
GLUR7 GPRC1G MGLU7 MGLUR7 |
glutamate receptor, metabotropic 7 | Taurine results in decreased expression of GRM7 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 2982 |
GUCY1A3
GC-SA3 GUC1A3 GUCA3 GUCSA3 GUCY1A1 |
guanylate cyclase 1, soluble, alpha 3 (EC:4.6.1.2) | Taurine results in decreased expression of GUCY1A3 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | Taurine results in decreased expression of HMGB1 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 3486 |
IGFBP3
BP-53 IBP3 |
insulin-like growth factor binding protein 3 | Taurine results in decreased expression of IGFBP3 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 889 |
KRIT1
CAM CCM1 |
KRIT1, ankyrin repeat containing | Taurine results in increased expression of KRIT1 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 10314 |
LANCL1
GPR69A p40 |
LanC lantibiotic synthetase component C-like 1 (bacterial) | Taurine results in increased expression of LANCL1 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 4067 |
LYN
JTK8 p53Lyn p56Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2) | Taurine results in decreased expression of LYN mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 64231 |
MS4A6A
4SPAN3 4SPAN3.2 CD20L3 MS4A6 MST090 MSTP090 |
membrane-spanning 4-domains, subfamily A, member 6A | Taurine results in decreased expression of MS4A6A mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 81285 |
OR51E2
OR51E3P OR52A2 PSGR |
olfactory receptor, family 51, subfamily E, member 2 | Taurine results in decreased expression of OR51E2 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 55824 |
PAG1
CBP PAG |
phosphoprotein associated with glycosphingolipid microdomains 1 | Taurine results in decreased expression of PAG1 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 10298 |
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4 (EC:2.7.11.1) | Taurine results in decreased expression of PAK4 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 5423 |
POLB
|
polymerase (DNA directed), beta (EC:2.7.7.7) | Taurine results in increased expression of POLB mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 5424 |
POLD1
CDC2 CRCS10 MDPL POLD |
polymerase (DNA directed), delta 1, catalytic subunit (EC:2.7.7.7) | Taurine results in increased expression of POLD1 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 27434 |
POLM
Pol_Mu Tdt-N |
polymerase (DNA directed), mu (EC:2.7.7.7) | Taurine results in increased expression of POLM mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 26051 |
PPP1R16B
ANKRD4 TIMAP |
protein phosphatase 1, regulatory subunit 16B | Taurine results in increased expression of PPP1R16B mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 5529 |
PPP2R5E
|
protein phosphatase 2, regulatory subunit B', epsilon isoform | Taurine results in decreased expression of PPP2R5E mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 5577 |
PRKAR2B
PRKAR2 RII-BETA |
protein kinase, cAMP-dependent, regulatory, type II, beta (EC:2.7.11.1) | Taurine results in decreased expression of PRKAR2B mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 5664 |
PSEN2
AD3L AD4 CMD1V PS2 STM2 |
presenilin 2 (Alzheimer disease 4) | Taurine results in decreased expression of PSEN2 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 5796 |
PTPRK
R-PTP-kappa |
protein tyrosine phosphatase, receptor type, K (EC:3.1.3.48) | Taurine results in decreased expression of PTPRK mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 5868 |
RAB5A
RAB5 |
RAB5A, member RAS oncogene family | Taurine results in decreased expression of RAB5A mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 5889 |
RAD51C
BROVCA3 FANCO R51H3 RAD51L2 |
RAD51 paralog C | Taurine results in increased expression of RAD51C mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 5883 |
RAD9A
RAD9 |
RAD9 homolog A (S. pombe) (EC:3.1.11.2) | Taurine results in increased expression of RAD9A mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 9693 |
RAPGEF2
CNrasGEF NRAPGEP PDZ-GEF1 PDZGEF1 RA-GEF RA-GEF-1 Rap-GEP nRap_GEP |
Rap guanine nucleotide exchange factor (GEF) 2 | Taurine results in decreased expression of RAPGEF2 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 10125 |
RASGRP1
CALDAG-GEFI CALDAG-GEFII RASGRP V hRasGRP1 |
RAS guanyl releasing protein 1 (calcium and DAG-regulated) | Taurine results in increased expression of RASGRP1 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 6196 |
RPS6KA2
HU-2 MAPKAPK1C RSK RSK3 S6K-alpha S6K-alpha2 p90-RSK3 pp90RSK3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 (EC:2.7.11.1) | Taurine results in increased expression of RPS6KA2 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 6447 |
SCG5
7B2 P7B2 SGNE1 SgV |
secretogranin V (7B2 protein) | Taurine results in increased expression of SCG5 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 9126 |
SMC3
BAM BMH CDLS3 CSPG6 HCAP SMC3L1 |
structural maintenance of chromosomes 3 | Taurine results in increased expression of SMC3 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 10302 |
SNAPC5
SNAP19 |
small nuclear RNA activating complex, polypeptide 5, 19kDa | Taurine results in increased expression of SNAPC5 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 10253 |
SPRY2
hSPRY2 |
sprouty homolog 2 (Drosophila) | Taurine results in increased expression of SPRY2 mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 6729 |
SRP54
|
signal recognition particle 54kDa | Taurine results in decreased expression of SRP54 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 6774 |
STAT3
APRF HIES |
signal transducer and activator of transcription 3 (acute-phase response factor) | Taurine results in decreased expression of STAT3 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 6869 |
TACR1
NK1R NKIR SPR TAC1R |
tachykinin receptor 1 | Taurine results in decreased expression of TACR1 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 7010 |
TEK
CD202B TIE-2 TIE2 VMCM VMCM1 |
TEK tyrosine kinase, endothelial (EC:2.7.10.1) | Taurine results in increased expression of TEK mRNA |
increases expression
|
mRNA |
16579726
|
| D013654 | 7040 |
TGFB1
CED DPD1 LAP TGFB TGFbeta |
transforming growth factor, beta 1 | Taurine inhibits the reaction [Silicon Dioxide results in increased expression of TGFB1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
19337903
|
| D013654 | 7040 |
TGFB1
CED DPD1 LAP TGFB TGFbeta |
transforming growth factor, beta 1 | Taurine inhibits the reaction [Silicon Dioxide results in increased expression of TGFB1 protein] |
decreases reaction
/ increases expression |
protein |
19337903
|
| D013654 | 9540 |
TP53I3
PIG3 |
tumor protein p53 inducible protein 3 | Taurine results in decreased expression of TP53I3 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 7297 |
TYK2
JTK1 |
tyrosine kinase 2 (EC:2.7.10.2) | Taurine results in decreased expression of TYK2 mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 7415 |
VCP
ALS14 IBMPFD IBMPFD1 TERA p97 |
valosin containing protein (EC:3.6.4.6) | Taurine results in decreased expression of VCP mRNA |
decreases expression
|
mRNA |
16579726
|
| D013654 | 7518 |
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4 | Taurine results in increased expression of XRCC4 mRNA |
increases expression
|
mRNA |
16579726
|
Related Disease
Diseases related to proteins in ChEMBL interactions
OMIM (21)
| OMIM | preferred title | UniProt |
|---|---|---|
| #210900 | Bloom syndrome; blm |
P54132
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
KEGG DISEASE (19)
| KEGG | disease name | UniProt |
|---|---|---|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
Diseases related to CTD interactions
38 disease from interactions of metabolites
| MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
|---|---|---|---|---|---|
| D055371 | D013654 | Acute Lung Injury |
therapeutic
|
19362168
|
|
| D000860 | D013654 | Anoxia |
therapeutic
|
2501810
|
|
| D001145 | D013654 | Arrhythmias, Cardiac |
therapeutic
|
125678
|
|
| D001919 | D013654 | Bradycardia |
marker/mechanism
|
1451572
6621821 |
|
| D009202 | D013654 | Cardiomyopathies |
therapeutic
|
15231041
|
|
| D003329 | D013654 | Coronary Vasospasm |
marker/mechanism
|
19120009
|
|
| D003921 | D013654 | Diabetes Mellitus, Experimental |
therapeutic
|
22138235
|
|
| D003922 | D013654 | Diabetes Mellitus, Type 1 |
therapeutic
|
22138235
|
|
| D058065 | D013654 | Diabetic Cardiomyopathies |
therapeutic
|
16025228
22138235 |
|
| D003928 | D013654 | Diabetic Nephropathies |
therapeutic
|
7573492
|
|
| D056486 | D013654 | Drug-Induced Liver Injury |
therapeutic
|
9328219
20166895 20830294 |
|
| D050171 | D013654 | Dyslipidemias |
therapeutic
|
22138235
|
|
| D004487 | D013654 | Edema |
therapeutic
|
15743398
|
|
| D019446 | D013654 | Endotoxemia |
therapeutic
|
20056113
|
|
| D005198 | D013654 | Fanconi Syndrome |
therapeutic
|
10063969
|
|
| D005355 | D013654 | Fibrosis |
therapeutic
|
19362168
|
|
| D005923 | D013654 | Glomerulosclerosis, Focal Segmental |
therapeutic
|
1733287
|
|
| D006323 | D013654 | Heart Arrest |
marker/mechanism
|
19120009
|
|
| D006331 | D013654 | Heart Diseases |
therapeutic
|
18561905
19616567 |
|
| D006470 | D013654 | Hemorrhage |
therapeutic
|
15743398
|
|
| D006943 | D013654 | Hyperglycemia |
therapeutic
|
22138235
|
|
| D017495 | D013654 | Hyperpigmentation |
therapeutic
|
20804622
|
|
| D006973 | D013654 | Hypertension |
therapeutic
|
20360751
|
|
| D006984 | D013654 | Hypertrophy |
therapeutic
|
19553346
|
|
| D007022 | D013654 | Hypotension |
marker/mechanism
|
1451572
6621821 |
|
| D007249 | D013654 | Inflammation |
therapeutic
|
21470069
|
|
| D007674 | D013654 | Kidney Diseases |
therapeutic
|
17698946
18414974 20067817 |
|
| D007859 | D013654 | Learning Disorders |
therapeutic
|
2501810
|
|
| D008106 | D013654 | Liver Cirrhosis, Experimental |
therapeutic
|
15893842
15931870 |
|
| D009069 | D013654 | Movement Disorders |
marker/mechanism
|
2727012
|
|
| D009133 | D013654 | Muscular Atrophy |
therapeutic
|
16318624
|
|
| D009203 | D013654 | Myocardial Infarction |
marker/mechanism
therapeutic |
16259760
19120009 |
|
| D009336 | D013654 | Necrosis |
therapeutic
|
20166895
|
|
| D009845 | D013654 | Oligospermia |
therapeutic
|
19429265
20498001 |
|
| D011014 | D013654 | Pneumonia |
marker/mechanism
|
19362168
|
|
| D011507 | D013654 | Proteinuria |
therapeutic
|
20360751
|
|
| D012640 | D013654 | Seizures |
marker/mechanism
therapeutic |
1276935
2501810 11140358 17728537 |
|
| D013733 | D013654 | Testicular Diseases |
therapeutic
|
19429265
|